PetCaseFinder

Peer-reviewed veterinary case report

Different c-KIT mutations found in a cat's splenic mast cell tumor

By Hasegawa, Yuki et al.·Published in Scientific reports·2022·Joint Faculty of Veterinary Medicine, Japan·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Intratumoral heterogeneity of c-KIT mutations in a feline splenic mast cell tumor and their functional effects on cell proliferation.

Species:
cat
Skin & coatCats

Plain-English summary

A cat with skin and spleen tumors was diagnosed with mast cell tumors (MCTs) after a lab test revealed a mutation in a specific gene (c-KIT). The cat was treated with a medication called toceranib, which initially led to complete remission. However, the tumors returned after about four months, and despite surgery to remove them, the cat sadly passed away about six months later. Researchers found that the tumors had different genetic patterns, which may have contributed to their growth and recurrence.

People also search for: cat mast cell tumor treatment · feline cancer gene mutations · toceranib for cat tumors

Abstract

A cat was presented with mast cell tumors (MCTs) of the skin and spleen. During the initial diagnosis, the exon 8 mutation of c-KIT was detected in the masses from skin and spleen by a commercial laboratory test. Consequently, treatment with toceranib was started. After complete remission, because of recurrence on day 117, the spleen and skin tumors were removed, but the cat eventually died on day 191. The analysis of ten cDNA clones of the c-KIT gene cloned from the surgically removed spleen revealed that seven different cDNA patterns were included, indicating the heterogeneity of this gene in the splenic MCT. The seven cDNA nucleotide patterns can be classified into four protein sequence patterns. In addition to the previously known mutations in exon 8, we identified novel mutations in exons 9, 10, and 18; four amino acids deletion in exon 9, and a point mutation in exons 10 and 18. Mouse IL-3-dependent cell line, Ba/F3, was transduced with these mutant clones, and c-KIT phosphorylation and proliferation assays were performed. We found that certain mutations affected the c-KIT phosphorylation status and cell proliferation. This suggests that heterogeneity among the population of tumor cells exists in MCTs, and that the dominant clones of this heterogeneity may contribute to the subsequent tumor cell growth.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/36138037/